These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 12780665

  • 1. Steroid-free immunosuppression during and after liver transplantation--a 3-yr follow-up report.
    Pirenne J, Aerts R, Koshiba T, Van Gelder F, Roskams T, Schetz M, Verhaegen M, Lauwers P, Fevery J, Nevens F.
    Clin Transplant; 2003 Jun; 17(3):177-82. PubMed ID: 12780665
    [Abstract] [Full Text] [Related]

  • 2. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study.
    Lerut JP, Ciccarelli O, Mauel E, Gheerardhyn R, Talpe S, Sempoux C, Laterre PF, Roggen FM, Van Leeuw V, Otte JB, Gianello P.
    Transpl Int; 2001 Dec; 14(6):420-8. PubMed ID: 11793040
    [Abstract] [Full Text] [Related]

  • 3. Quadruple tacrolimus-based induction therapy including azathioprine and ALG does not significantly improve outcome after liver transplantation when compared with standard induction with tacrolimus and steroids: results of a prospective, randomized trial.
    Neuhaus P, Klupp J, Langrehr JM, Neumann U, Gebhardt A, Pratschke J, Tullius SG, Lohmann R, Radke C, Rayes N, Neuhaus R, Bechstein WO.
    Transplantation; 2000 Jun 15; 69(11):2343-53. PubMed ID: 10868638
    [Abstract] [Full Text] [Related]

  • 4. Reasons for long-term use of steroid in primary adult liver transplantation under tacrolimus.
    Jain A, Kashyap R, Marsh W, Rohal S, Khanna A, Fung JJ.
    Transplantation; 2001 Apr 27; 71(8):1102-6. PubMed ID: 11374410
    [Abstract] [Full Text] [Related]

  • 5. A pilot study of immunosuppressive monotherapy in liver transplantation: tacrolimus versus microemulsified cyclosporin.
    Rolles K, Davidson BR, Burroughs AK.
    Transplantation; 1999 Oct 27; 68(8):1195-8. PubMed ID: 10551650
    [Abstract] [Full Text] [Related]

  • 6. Outcome after steroid withdrawal in pediatric renal transplant patients receiving tacrolimus-based immunosuppression.
    Chakrabarti P, Wong HY, Scantlebury VP, Jordan ML, Vivas C, Ellis D, Lombardozzi-Lane S, Hakala TR, Fung JJ, Simmons RL, Starzl TE, Shapiro R.
    Transplantation; 2000 Sep 15; 70(5):760-4. PubMed ID: 11003353
    [Abstract] [Full Text] [Related]

  • 7. Results of pancreas transplantation after steroid withdrawal under tacrolimus immunosuppression.
    Jordan ML, Chakrabarti P, Luke P, Shapiro R, Vivas CA, Scantlebury VP, Fung JJ, Starzl TE, Corry RJ.
    Transplantation; 2000 Jan 27; 69(2):265-71. PubMed ID: 10670637
    [Abstract] [Full Text] [Related]

  • 8. Tacrolimus (FK506) and mycophenolate mofetil combination therapy versus tacrolimus in adult liver transplantation.
    Eckhoff DE, McGuire BM, Frenette LR, Contreras JL, Hudson SL, Bynon JS.
    Transplantation; 1998 Jan 27; 65(2):180-7. PubMed ID: 9458011
    [Abstract] [Full Text] [Related]

  • 9. Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy.
    Eason JD, Nair S, Cohen AJ, Blazek JL, Loss GE.
    Transplantation; 2003 Apr 27; 75(8):1396-9. PubMed ID: 12717237
    [Abstract] [Full Text] [Related]

  • 10. Four-year follow-up of a prospective randomized trial of mycophenolate mofetil with cyclosporine microemulsion or tacrolimus following liver transplantation.
    Fisher RA, Stone JJ, Wolfe LG, Rodgers CM, Anderson ML, Sterling RK, Shiffman ML, Luketic VA, Contos MJ, Mills AS, Ferreira-Gonzalez A, Posner MP.
    Clin Transplant; 2004 Aug 27; 18(4):463-72. PubMed ID: 15233827
    [Abstract] [Full Text] [Related]

  • 11. Reasons why some children receiving tacrolimus therapy require steroids more than 5 years post liver transplantation.
    Jain A, Mazariegos G, Kashyap R, Marsh W, Khanna A, Iurlano K, Fung J, Reyes J.
    Pediatr Transplant; 2001 Apr 27; 5(2):93-8. PubMed ID: 11328546
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Initial experience with FK506 (tacrolimus) in pediatric renal transplant recipients.
    McKee M, Segev D, Wise B, Case B, Neu A, Fivush B, Colombani P.
    J Pediatr Surg; 1997 May 27; 32(5):688-90. PubMed ID: 9165452
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK, Montagnino G, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Krüger B, Ortuño J, Köhler H, Kunzendorf U, Stummvoll HK, Tabernero JM, Mühlbacher F, Rivero M, Arias M, European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group.
    Nephrol Dial Transplant; 2005 May 27; 20(5):968-73. PubMed ID: 15741208
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Preoperative introduction and maintenance immunosuppression therapy of oral-only tacrolimus, mycophenolate mofetil and steroids reduce acute rejection episodes after lung transplantation.
    Bittner HB, Barten MJ, Binner C, Lehmann S, Garbade J, Hammerschmidt S, Wirtz H, Mohr FW.
    Eur J Cardiothorac Surg; 2010 Sep 27; 38(3):268-76. PubMed ID: 20304665
    [Abstract] [Full Text] [Related]

  • 17. A novel management strategy of steroid-free immunosuppression after liver transplantation: efficacy and safety of tacrolimus and mycophenolate mofetil.
    Ringe B, Braun F, Schütz E, Füzesi L, Lorf T, Canelo R, Oellerich M, Ramadori G.
    Transplantation; 2001 Feb 27; 71(4):508-15. PubMed ID: 11258429
    [Abstract] [Full Text] [Related]

  • 18. The use of an anti-CD25 monoclonal antibody and mycophenolate mofetil enables the use of a low-dose tacrolimus and early withdrawal of steroids in renal transplant recipients.
    Kuypers DR, Evenepoel P, Maes B, Coosemans W, Pirenne J, Vanrenterghem Y.
    Clin Transplant; 2003 Jun 27; 17(3):234-41. PubMed ID: 12780674
    [Abstract] [Full Text] [Related]

  • 19. Early tacrolimus exposure after liver transplantation: relationship with moderate/severe acute rejection and long-term outcome.
    Rodríguez-Perálvarez M, Germani G, Papastergiou V, Tsochatzis E, Thalassinos E, Luong TV, Rolando N, Dhillon AP, Patch D, O'Beirne J, Thorburn D, Burroughs AK.
    J Hepatol; 2013 Feb 27; 58(2):262-70. PubMed ID: 23023010
    [Abstract] [Full Text] [Related]

  • 20. Low rejection rates with tacrolimus-based dual and triple regimens following liver transplantation.
    Boillot O, Baulieux J, Wolf P, Messner M, Cherqui D, Gugenheim J, Pageaux G, Belghiti J, Calmus Y, Le Treut Y, Neau-Cransac M, Samuel D.
    Clin Transplant; 2001 Jun 27; 15(3):159-66. PubMed ID: 11389705
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.